Catalyst Wire Dossier Catalyst Wire Dossier

AZOPT 1.0%

brinzolamide · Alcon Research
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZOPT 1.0%, covering 2016-11-18 to 2016-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension [Phase 3]

See pricing